Illegal Activity
none
Blackmail
none
Date
2015-08-14
Document Type
email
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:41
Summary
Vahe Stepanian informs Jeffrey E. about the decline in Avalanche Bio's stock price following the company's decision to scrap a Phase 2b trial. Southern Financial is experiencing an unrealized loss on its investment in AAVL, and Stepanian seeks guidance on how to proceed.
Metadata
- Subject
- FW: (BFW) Avalanche Bio Falls After Scrapping Plans for Ph.2b Study [C]
- Sender
- Vahe Stepanian
- Recipients
- jeffrey E.
- Document ID
- —
- Date
- 2015-08-14
Relationships 2
| Entity 1 | Relationship | Entity 2 | Description |
|---|---|---|---|
| Vahe Stepanian | email correspondence | Jeffrey E. | Vahe Stepanian is informing Jeffrey E. about the stock performance of Avalanche Bio. |
| Southern Financial | investment | Avalanche Bio | Southern Financial holds 10,000 shares of Avalanche Bio. |
Notable Quotes 2
The stock is down —25% today to $10.289 on the back of news that it plans to scrap a planned Phase 2b trial
Recall that Southern Financial is long 10,000 AAVL @ $39.86, purchased 4/20/2015 (unrealized loss —$295k).
Financial Information
Amounts:10.28939.86295k279.6m159.4m0.2m0.4m38c37c
Assets:
- AAVL shares
- Cash/equivalents
Transactions:
- Southern Financial purchased 10,000 AAVL shares @ $39.86 on 4/20/2015
Media & Journalist References
- {'email': 'jcooke8@bloomberg.net', 'person': 'Jeremy R. Cooke', 'contact': '+1-617-210-4654', 'organization': 'Bloomberg'}
Public Knowledge
- Context
- The information is based on a Bloomberg news report, indicating it is likely public knowledge.
- Media Worthy
- Yes
- Likely Public
- True
Raw Analysis JSON
click to expand
Themes
Financial transactions/money flowBusiness dealingsCommunications/correspondence
People 8
Organizations 5
Avalanche BioSouthern FinancialBloombergDeutsche Bank SecuritiesAvalanche Biotechnologies
Text Analysis
- Tone
- Informative, professional
- Purpose
- To inform Jeffrey E. about the decline in Avalanche Bio's stock price and the unrealized loss for Southern Financial, and to inquire about how to proceed.
- Significance
- The document highlights a significant drop in Avalanche Bio's stock price and the potential financial impact on Southern Financial's investment.
File Info
- File Name
- EFTA01412850.txt
- Dataset
- dataset_10
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:41:20.984837
- DOJ Source
- View on DOJ